Literature DB >> 4038658

Evaluation of luteal-phase salivary progesterone levels in women with benign breast disease or primary breast cancer.

G F Read, J A Bradley, D W Wilson, W D George, K Griffiths.   

Abstract

Salivary progesterone concentrations were determined in premenopausal parous women with a mean age of ca. 40 yr who had a history of either benign breast disease (n = 15) or primary breast cancer (n = 15) and in a group of age-matched healthy women (n = 15). Saliva samples were collected at 09.00 and 21.00 hr daily for one complete menstrual cycle and progesterone concentration was measured by radioimmunoassay. Characteristic luteal-phase progesterone profiles were observed in all subjects in each of the three groups but no statistical intergroup differences could be demonstrated for age-matched subjects in each group. These studies indicated that ovarian dysfunction, as judged from salivary progesterone concentrations, was not apparent in older premenopausal women with a history of benign breast disease or primary breast cancer when compared with age-matched controls.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038658     DOI: 10.1016/0277-5379(85)90194-4

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  7 in total

1.  The luteal heat cycle of the breast in disease.

Authors:  H W Simpson; K Griffiths; C McArdle; A W Pauson; P Hume; A Turkes
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 2.  The endocrine basis of benign breast disorders.

Authors:  L Dogliotti; F Orlandi; A Angeli
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

Review 3.  Breast pain.

Authors:  Amit Goyal
Journal:  BMJ Clin Evid       Date:  2011-01-17

4.  The luteal heat cycle of the breast in health.

Authors:  H W Simpson; K Griffiths; C McArdle; A W Pauson; P Hume; A Turkes
Journal:  Breast Cancer Res Treat       Date:  1993-09       Impact factor: 4.872

5.  Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease.

Authors:  C Nappi; P Affinito; C Di Carlo; G Esposito; U Montemagno
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

6.  The Chronobra identifies prevailing mammary vascularity as a candidate variable in breast cancer post-operative outcome prediction.

Authors:  Hugh W Simpson; David George; Robert B Sothern; Keith Griffiths
Journal:  Springerplus       Date:  2013-05-24

7.  Pregnancy postponement and childlessness leads to chronic hypervascularity of the breasts and cancer risk.

Authors:  H W Simpson; C S McArdle; W D George; K Griffiths; A Turkes; A W Pauson
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.